Ian Lennox

Guest Contributor
May 10, 2004

Ian Lennox has resigned from MDS Inc to pursue other interests. Lennox joined the Toronto-based company in 2000 when it acquired Phoenix International Life Sciences Inc, of which he was president and CEO. He led the integration of the two companies and contributed to the analytical and proteomics businesses. Most recently he was group president and CEO of MDS’ pharmaceutical and biotech markets division. Lennox’s departure comes as MDS creates the new executive position of chief operating officer. A search is underway to fill the position….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.